This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovations of Donald L Bussolotti
Introduction
Donald L Bussolotti is a notable inventor based in Ledyard, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-diabetic agents. With a total of 2 patents to his name, Bussolotti's work has the potential to impact the treatment of various diabetes-related conditions.
Latest Patents
Bussolotti's latest patents include innovative compounds designed to combat diabetes. The first patent focuses on anti-diabetic agents, providing compounds of formula (I), including their stereoisomers and prodrugs, as well as pharmaceutically acceptable salts. These compounds are aimed at improving the treatment options available for diabetes. The second patent involves N-(indole-2-carbonyl) and H-thieno[2,3-b]pyrrole-5-carboxamide anti-diabetic agents. This invention also presents compounds of formula (I) and their prodrugs, which are intended for use in treating a range of diabetes-related issues, including insulin resistance, diabetic neuropathy, and hyperglycemia.
Career Highlights
Donald L Bussolotti is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on developing innovative solutions for diabetes management. Bussolotti's expertise in pharmaceutical chemistry has been instrumental in advancing the understanding and treatment of diabetes.
Collaborations
Throughout his career, Bussolotti has collaborated with several talented individuals, including Ronald B Gammill and Jana Polivkova. These collaborations have fostered a productive environment for innovation and have contributed to the success of his projects.
Conclusion
Donald L Bussolotti's contributions to the field of anti-diabetic agents highlight his commitment to improving healthcare outcomes for individuals with diabetes. His innovative patents and collaborations with esteemed colleagues underscore the importance of teamwork in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile